University Hospital, Basel, Switzerland Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT01545297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Dirk Fischer | Mirjam Christ-Crain

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Metabolic Syndrome (Phase 3)

Obesity (Phase 3)

Poliomyelitis (Phase 3)

Postpoliomyelitis Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6